NO156286C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidderivater.

Info

Publication number
NO156286C
NO156286C NO820762A NO820762A NO156286C NO 156286 C NO156286 C NO 156286C NO 820762 A NO820762 A NO 820762A NO 820762 A NO820762 A NO 820762A NO 156286 C NO156286 C NO 156286C
Authority
NO
Norway
Prior art keywords
group
lower alkyl
preparation
same
acyl
Prior art date
Application number
NO820762A
Other languages
English (en)
Norwegian (no)
Other versions
NO820762L (no
NO156286B (no
Inventor
Goesta Lennart Florvall
Jan Ola Gustaf Lundstroem
Sten Ingvar Raemsby
Sven Ove Oegren
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of NO820762L publication Critical patent/NO820762L/no
Priority to NO863924A priority Critical patent/NO863924D0/no
Publication of NO156286B publication Critical patent/NO156286B/no
Publication of NO156286C publication Critical patent/NO156286C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
NO820762A 1981-03-11 1982-03-10 Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidderivater. NO156286C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO863924A NO863924D0 (no) 1981-03-11 1986-10-02 Mellomprodukter for bruk ved fremstilling av terapeutisk virksomme benzamidderivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8101536A SE8101536L (sv) 1981-03-11 1981-03-11 Bensamid-derivat

Publications (3)

Publication Number Publication Date
NO820762L NO820762L (no) 1982-09-13
NO156286B NO156286B (no) 1987-05-18
NO156286C true NO156286C (no) 1987-08-26

Family

ID=20343304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820762A NO156286C (no) 1981-03-11 1982-03-10 Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidderivater.

Country Status (30)

Country Link
US (1) US4789683A (fr)
EP (1) EP0060235B1 (fr)
JP (1) JPS57159762A (fr)
KR (1) KR890001375B1 (fr)
AT (1) ATE17346T1 (fr)
AU (1) AU553041B2 (fr)
BG (4) BG41126A3 (fr)
CA (1) CA1167457A (fr)
CS (1) CS266310B2 (fr)
CY (1) CY1440A (fr)
DD (1) DD201886A5 (fr)
DE (1) DE3268354D1 (fr)
DK (1) DK159968C (fr)
ES (4) ES8307742A1 (fr)
FI (1) FI76785C (fr)
GR (1) GR75892B (fr)
HK (1) HK66288A (fr)
HU (1) HU186042B (fr)
IE (1) IE52608B1 (fr)
IL (1) IL65035A0 (fr)
MY (1) MY8600526A (fr)
NO (1) NO156286C (fr)
NZ (1) NZ199925A (fr)
PH (1) PH19661A (fr)
PL (4) PL135700B1 (fr)
PT (1) PT74563B (fr)
RO (4) RO82956B (fr)
SE (1) SE8101536L (fr)
SU (4) SU1156593A3 (fr)
ZA (1) ZA821017B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
SE8400478D0 (sv) * 1984-01-31 1984-01-31 Astra Laekemedel Ab Oxysalicylamido derivatives
US5240957A (en) * 1984-01-31 1993-08-31 Astra Lakemedel Akteibolag Oxysalicylamido derivatives
FR2578539B1 (fr) * 1985-03-08 1987-09-04 Therapeutiques Ste Monega Et Nouveaux benzamides de l'acide 2,4,6-trimethoxybenzoique, leur procede de preparation et leur utilisation
SE8503054D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Catecholcarboxamides
GB8708833D0 (en) * 1987-04-13 1987-05-20 Lilly S A E Organic compounds
EP0320630A1 (fr) * 1987-11-19 1989-06-21 The Vanderbilt University Iodobenzamides énantiomeriques
GB8823040D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
US5248817A (en) * 1991-07-15 1993-09-28 Merck & Co., Inc. Process for aromatic bromination
US5446147A (en) * 1992-04-03 1995-08-29 Trustees Of The University Of Pennsylvania Fluorinated and iodinated dopamine agents
DK72693D0 (da) * 1993-06-18 1993-06-18 Lundbeck & Co As H Compounds
JP4275819B2 (ja) * 1999-09-17 2009-06-10 飯田 秀博 デメチルラクロプライドの非求核性酸塩およびこれを用いる［ｃ−１１］ラクロプライドの製造法
DK178705B1 (en) * 2015-07-07 2016-11-28 Silversnow Aps A heat pump system using water as the thermal fluid

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (fr) * 1966-01-21 1968-05-06
BE695272A (fr) * 1967-03-09 1967-09-11
CH507938A (fr) * 1968-08-01 1971-05-31 Ile De France Procédé de préparation de benzamides hétérocycliques
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
US3793030A (en) * 1971-09-02 1974-02-19 Ricoh Kk Process for producing diazotype light-sensitive material
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
IT1070992B (it) * 1973-12-21 1985-04-02 Italfarmaco Spa Processo per la preparazione della i etil 2 2 metossi 5 sulfamoil benzamidometil pirrolidina
CH605793A5 (fr) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4172143A (en) * 1974-12-18 1979-10-23 Synthelabo 2-Methoxy-benzamide derivatives
JPS5319447A (en) * 1976-08-07 1978-02-22 Igeta Seikou Kk Manufacture of endless wire rope
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
SE411118B (sv) * 1978-03-23 1979-12-03 Astra Laekemedel Ab Ett forfarande for framstellning av 2,6-dialkoxibensamider med terapentiska egenskaper
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire

Also Published As

Publication number Publication date
GR75892B (fr) 1984-08-02
SU1241986A3 (ru) 1986-06-30
JPH0331704B2 (fr) 1991-05-08
BG41125A3 (en) 1987-04-15
CS266310B2 (en) 1989-12-13
PT74563A (en) 1982-04-01
ES510278A0 (es) 1983-08-01
PH19661A (en) 1986-06-09
ZA821017B (en) 1983-01-26
PL235397A1 (en) 1983-07-18
FI820544L (fi) 1982-09-12
ES8401459A1 (es) 1983-12-01
NZ199925A (en) 1985-08-30
KR890001375B1 (ko) 1989-05-02
IE820544L (en) 1982-09-11
FI76785B (fi) 1988-08-31
IL65035A0 (en) 1982-04-30
RO86081A (fr) 1985-02-25
SE8101536L (sv) 1982-09-12
CS156882A2 (en) 1989-02-10
PL240321A1 (en) 1983-08-15
NO820762L (no) 1982-09-13
PL135700B1 (en) 1985-11-30
BG39976A3 (en) 1986-09-15
PL135699B1 (en) 1985-11-30
AU553041B2 (en) 1986-07-03
DD201886A5 (de) 1983-08-17
CA1167457A (fr) 1984-05-15
RO86083A2 (fr) 1985-02-25
ATE17346T1 (de) 1986-01-15
BG41124A3 (en) 1987-04-15
RO86082B (ro) 1985-03-01
RO86082A (fr) 1985-02-25
DK103782A (da) 1982-09-12
PL135475B1 (en) 1985-10-31
KR830009022A (ko) 1983-12-17
EP0060235B1 (fr) 1986-01-08
AU8116082A (en) 1982-09-16
HU186042B (en) 1985-05-28
ES8401458A1 (es) 1983-12-01
ES520193A0 (es) 1983-12-01
MY8600526A (en) 1986-12-31
BG41126A3 (en) 1987-04-15
JPS57159762A (en) 1982-10-01
DE3268354D1 (de) 1986-02-20
IE52608B1 (en) 1987-12-23
CY1440A (en) 1989-03-10
HK66288A (en) 1988-09-02
PL240322A1 (en) 1983-08-15
ES520192A0 (es) 1983-12-01
EP0060235A1 (fr) 1982-09-15
PT74563B (en) 1984-11-27
ES8307742A1 (es) 1983-08-01
US4789683A (en) 1988-12-06
ES8401460A1 (es) 1983-12-01
NO156286B (no) 1987-05-18
RO86083B1 (ro) 1985-03-01
SU1261561A3 (ru) 1986-09-30
DK159968C (da) 1991-05-27
PL240323A1 (en) 1983-08-15
SU1156593A3 (ru) 1985-05-15
RO82956A (fr) 1984-01-14
FI76785C (fi) 1988-12-12
DK159968B (da) 1991-01-07
RO86081B (ro) 1985-03-01
PL136457B1 (en) 1986-02-28
ES520194A0 (es) 1983-12-01
RO82956B (ro) 1984-01-30
SU1355122A3 (ru) 1987-11-23

Similar Documents

Publication Publication Date Title
NO156286C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidderivater.
DK403883A (da) Fremgangsmaade til fremstilling af benzamidoderivater
FI945582A (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
NO151465C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater og syreaddisjonssalter derav
NO803862L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater
NO171363C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksysalicylaminoderivater